Legend Biotech Corporation
LEGN
$34.86
$1.374.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 834.60M | 948.60M | 992.59M | 967.56M | 1.01B |
| Total Receivables | 186.60M | 250.30M | 202.57M | 228.99M | 166.85M |
| Inventory | 37.10M | 32.00M | 29.18M | 35.59M | 30.93M |
| Prepaid Expenses | 19.40M | 14.60M | 17.59M | 17.67M | 15.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.00M | 1.60M | 70.00K | 70.00K | 70.00K |
| Total Current Assets | 1.08B | 1.25B | 1.24B | 1.25B | 1.22B |
|
|
|||||
| Total Current Assets | 1.08B | 1.25B | 1.24B | 1.25B | 1.22B |
| Net Property, Plant & Equipment | 452.50M | 401.50M | 253.74M | 233.60M | 206.03M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | 2.14M | 2.08M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 61.50M | 85.10M | 217.20M | 204.31M | 188.74M |
| Total Assets | 1.60B | 1.73B | 1.71B | 1.69B | 1.62B |
|
|
|||||
| Total Accounts Payable | 74.30M | 83.00M | 102.46M | 75.36M | 58.14M |
| Total Accrued Expenses | -- | 123.00M | -- | -- | 57.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 277.20M | 326.50M | 150.25M | 5.91M | 5.34M |
| Total Finance Division Other Current Liabilities | 157.60M | 103.90M | 180.87M | 184.22M | 113.07M |
| Total Other Current Liabilities | 157.60M | 103.90M | 180.87M | 184.22M | 113.07M |
| Total Current Liabilities | 509.10M | 636.40M | 433.57M | 265.48M | 234.37M |
|
|
|||||
| Total Current Liabilities | 509.10M | 636.40M | 433.57M | 265.48M | 234.37M |
| Long-Term Debt | -- | -- | 171.93M | 310.26M | 305.75M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 112.10M | 87.20M | 88.06M | 71.74M | 51.72M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.80M | 8.00M | 8.13M | 6.89M | 6.06M |
| Total Liabilities | 629.00M | 731.60M | 701.69M | 654.38M | 597.90M |
|
|
|||||
| Common Stock & APIC | 2.78B | 2.75B | 2.74B | 2.73B | 2.71B |
| Retained Earnings | -2.01B | -1.96B | -1.93B | -1.89B | -1.76B |
| Treasury Stock & Other | 199.50M | 210.20M | 200.63M | 189.14M | 67.52M |
| Total Common Equity | 967.70M | 1.00B | 1.01B | 1.04B | 1.02B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 967.70M | 1.00B | 1.01B | 1.04B | 1.02B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 967.70M | 1.00B | 1.01B | 1.04B | 1.02B |
|
|
|||||